Home / Inspections / 1151199

FDA Inspection 1151199 — Nesher Pharmaceuticals (USA) LLC

Nesher Pharmaceuticals (USA) LLC — FEI 1922352

The FDA completed an inspection of Nesher Pharmaceuticals (USA) LLC on August 12, 2021 in Bridgeton, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 12, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bridgeton, MO (United States)

Facility

Other inspections at this facility

  • 1092585 (VAI Fri May 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1040785 (NAI Thu Jan 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1002473 (VAI Fri Feb 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 926755 (VAI Thu May 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 854899 (NAI Fri Nov 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources